Boehringer Ingelheim Sees Advantages of Freshly Mixed Vaccine

GERMANY - Boehringer Ingelheim Animal Health has decided to remain focused on freshly mixed Porcine Circovirus type 2 (PCV2)/ Mycoplasma hyopneumoniae (M.hyo) vaccines and not follow the development of a PCV2/M.hyo ready-to-use (RTU) vaccine combination.
calendar icon 2 September 2014
clock icon 2 minute read

Charlotte Rowney

© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.